grx1 cDNA ORF clone, Schizosaccharomyces pombe(fission yeast)

The following grx1 gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the grx1 cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.

***CloneID Accession No. Definition **Vector *Turnaround time Price (USD) Select
OSc102531 NM_001020190.2
Latest version!
Schizosaccharomyces pombe glutaredoxin Grx1 (grx1), mRNA. pcDNA3.1-C-(k)DYK or customized vector 9-11 $104.30
$149.00

ORF Online Only Promotion

Next-day Shipping ORF Clones ( in default vector with tag)
1 Clone 30% OFF
2-4 Clone 40% OFF
5 or more Clone 50% OFF
All Other ORF Clones
30% OFF

*Business Day

** You may select a custom vector to replace pcDNA3.1+/C-(K)DYK after clone is added to cart.

** GenScript guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories. In addition, please pay attention to the signal peptide, propeptide and transit peptide in target ORF, which may affect the choice of vector (N/C terminal tag vector).

***One clone ID might be correlated to multiple accession numbers, which share the same CDS sequence.

  • Reference Sequences (Refseq)
    CloneID OSc102531
    Clone ID Related Accession (Same CDS sequence) NM_001020190.2
    Accession Version NM_001020190.2 Latest version! Documents for ORF clone product in default vector
    Sequence Information ORF Nucleotide Sequence (Length: 306bp)
    Protein sequence
    SNP
    Vector pcDNA3.1-C-(k)DYK or customized vector User Manual
    Clone information Clone Map MSDS
    Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
    ORF Insert Method CloneEZ™ Seamless cloning technology
    Insert Structure linear
    Update Date 2018-04-02
    Organism Schizosaccharomyces pombe(fission yeast)
    Product glutaredoxin Grx1
    Comment Comment: PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. This record is derived from an annotated genomic sequence (NC_003424). On Dec 10, 2012 this sequence version replaced NM_001020190.1.

    1
    61
    121
    181
    241
    301
    ATGTCTAGTG TTGAATCATT TGTTGACTCT GCCGTTGCTG ACAACGATGT TGTTGTTTTT 
    GCCAAGTCTT ACTGCCCTTA CTGCCATGCT ACTGAAAAGG TGATCGCTGA TAAGAAAATT
    AAGGCTCAGG TATACCAGAT TGACCTTATG AACAACGGTG ATGAGATTCA ATCTTACTTA
    TTGAAGAAGA CCGGTCAACG TACCGTACCC AATATCTTTA TTCACCAAAA GCATGTTGGT
    GGTAACTCGG ATTTCCAAGC ATTATTCAAG AAGGGCGAGC TCGACTCTCT TTTTAATACT
    GCCTAA

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    RefSeq NP_594763.1
    CDS105..410
    Translation

    Target ORF information:

    RefSeq Version NM_001020190.2
    Organism Schizosaccharomyces pombe(fission yeast)
    Definition Schizosaccharomyces pombe glutaredoxin Grx1 (grx1), mRNA.

    Target ORF information:

    Epitope DYKDDDDK
    Bacterial selection AMPR
    Mammalian selection NeoR
    Vector pcDNA3.1+/C-(K)DYK
    NM_001020190.2

    ORF Insert Sequence:

    1
    61
    121
    181
    241
    301
    ATGTCTAGTG TTGAATCATT TGTTGACTCT GCCGTTGCTG ACAACGATGT TGTTGTTTTT 
    GCCAAGTCTT ACTGCCCTTA CTGCCATGCT ACTGAAAAGG TGATCGCTGA TAAGAAAATT
    AAGGCTCAGG TATACCAGAT TGACCTTATG AACAACGGTG ATGAGATTCA ATCTTACTTA
    TTGAAGAAGA CCGGTCAACG TACCGTACCC AATATCTTTA TTCACCAAAA GCATGTTGGT
    GGTAACTCGG ATTTCCAAGC ATTATTCAAG AAGGGCGAGC TCGACTCTCT TTTTAATACT
    GCCTAA

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

  • PubMed

    The genome sequence of Schizosaccharomyces pombe.
    Nature415(6874)871-80(2002 Feb)
    Wood V,Gwilliam R,Rajandream MA,Lyne M,Lyne R,Stewart A,Sgouros J,Peat N,Hayles J,Baker S,Basham D,Bowman S,Brooks K,Brown D,Brown S,Chillingworth T,Churcher C,Collins M,Connor R,Cronin A,Davis P,Feltwell T,Fraser A,Gentles S,Goble A,Hamlin N,Harris D,Hidalgo J,Hodgson G,Holroyd S,Hornsby T,Howarth S,Huckle EJ,Hunt S,Jagels K,James K,Jones L,Jones M,Leather S,McDonald S,McLean J,Mooney P,Moule S,Mungall K,Murphy L,Niblett D,Odell C,Oliver K,O'Neil S,Pearson D,Quail MA,Rabbinowitsch E,Rutherford K,Rutter S,Saunders D,Seeger K,Sharp S,Skelton J,Simmonds M,Squares R,Squares S,Stevens K,Taylor K,Taylor RG,Tivey A,Walsh S,Warren T,Whitehead S,Woodward J,Volckaert G,Aert R,Robben J,Grymonprez B,Weltjens I,Vanstreels E,Rieger M,Sch?fer M,M?ller-Auer S,Gabel C,Fuchs M,D?sterh?ft A,Fritzc C,Holzer E,Moestl D,Hilbert H,Borzym K,Langer I,Beck A,Lehrach H,Reinhardt R,Pohl TM,Eger P,Zimmermann W,Wedler H,Wambutt R,Purnelle B,Goffeau A,Cadieu E,Dr?ano S,Gloux S,Lelaure V,Mottier S,Galibert F,Aves SJ,Xiang Z,Hunt C,Moore K,Hurst SM,Lucas M,Rochet M,Gaillardin C,Tallada VA,Garzon A,Thode G,Daga RR,Cruzado L,Jimenez J,S?nchez M,del Rey F,Benito J,Dom?nguez A,Revuelta JL,Moreno S,Armstrong J,Forsburg SL,Cerutti L,Lowe T,McCombie WR,Paulsen I,Potashkin J,Shpakovski GV,Ussery D,Barrell BG,Nurse P,Cerrutti L